ORAI1 and glioblastoma: Multiple groups have found STIM1 and Orai1 knockdown lead to a dramatic decrease in cell invasion in GBM, as such STIM1 has been proposed as a potential target in GBM treatment (Liu et al., 2011; Li G. et al., 2013; Motiani et al., 2013).